G1 THERAPEUTICS, INC. Revenue
G1 THERAPEUTICS, INC. reported Revenue of $16.55 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2024-08-08
- G1 THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-06-30 was $16.55M, a 60.97% decline year-over-year.
- G1 THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-03-31 was $14.48M, a 11.82% increase year-over-year.
- G1 THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-12-31 was $14.87M, a 45.10% increase year-over-year.
- G1 THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-09-30 was $12.30M, a 47.83% decline year-over-year.
- G1 THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $82.51M, a 60.84% increase from fiscal 2022.
- G1 THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $51.30M, a 62.98% increase from fiscal 2021.
- G1 THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $31.48M, a 30.49% decline from fiscal 2020.
- G1 THERAPEUTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $45.28M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2024-06-30 | $16.55M 10-Q · filed 2024-08-08 | $31.02M 10-Q · filed 2024-08-08 | $45.90M derived: sum of 3 quarters · filed 2024-08-08 | $58.20M derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $14.48M 10-Q · filed 2024-05-01 | $29.35M derived: sum of 2 quarters · filed 2024-05-01 | $41.65M derived: sum of 3 quarters · filed 2024-05-01 | $84.04M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $14.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $27.17M derived: sum of 2 quarters · filed 2024-02-28 | $69.56M derived: sum of 3 quarters · filed 2024-08-08 | $82.51M 10-K · filed 2024-02-28 |
| 2023-09-30 | $12.30M 10-Q · filed 2023-11-01 | $54.69M derived: sum of 2 quarters · filed 2024-08-08 | $67.64M 10-Q · filed 2023-11-01 | $77.89M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $42.39M 10-Q · filed 2024-08-08 | $55.34M 10-Q · filed 2024-08-08 | $65.59M derived: sum of 3 quarters · filed 2024-08-08 | $89.16M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $12.95M 10-Q · filed 2024-05-01 | $23.20M derived: sum of 2 quarters · filed 2024-05-01 | $46.77M derived: sum of 3 quarters · filed 2024-05-01 | $57.34M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $10.25M 10-K · filed 2023-03-01 | $33.83M derived: sum of 2 quarters · filed 2023-11-01 | $44.40M derived: sum of 3 quarters · filed 2023-11-01 | $51.30M 10-K · filed 2024-02-28 |
| 2022-09-30 | $23.58M 10-Q · filed 2023-11-01 | $34.15M derived: sum of 2 quarters · filed 2023-11-01 | $41.05M 10-Q · filed 2023-11-01 | $46.85M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $10.57M 10-Q · filed 2023-08-02 | $17.48M 10-Q · filed 2023-08-02 | $23.27M derived: sum of 3 quarters · filed 2023-08-02 | $28.13M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $6.90M 10-Q · filed 2023-05-03 | $12.70M derived: sum of 2 quarters · filed 2023-05-03 | $17.56M derived: sum of 3 quarters · filed 2023-05-03 | $24.16M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $5.80M 10-K · filed 2023-03-01 | $10.65M derived: sum of 2 quarters · filed 2023-03-01 | $17.26M derived: sum of 3 quarters · filed 2023-03-01 | $31.48M 10-K · filed 2024-02-28 |
| 2021-09-30 | $4.86M 10-K · filed 2023-03-01 | $11.46M derived: sum of 2 quarters · filed 2023-03-01 | $25.68M 10-Q · filed 2022-11-02 | $42.23M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $6.60M 10-K · filed 2023-03-01 | $20.82M 10-Q · filed 2022-08-03 | $37.37M derived: sum of 3 quarters · filed 2023-03-01 | $63.97M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $14.22M 10-K · filed 2023-03-01 | $30.76M derived: sum of 2 quarters · filed 2023-03-01 | $57.36M derived: sum of 3 quarters · filed 2023-03-01 | $59.50M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $16.55M 10-K · filed 2022-02-23 | $43.15M derived: sum of 2 quarters · filed 2022-02-23 | $45.28M derived: sum of 3 quarters · filed 2022-02-23 | $45.28M 10-K · filed 2023-03-01 |
| 2020-09-30 | $26.60M 10-K · filed 2022-02-23 | $28.74M derived: sum of 2 quarters · filed 2022-02-23 | $28.74M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $2.14M 10-K · filed 2022-02-23 | $2.14M 10-Q · filed 2021-08-04 |